|
PPP2CA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.36879999995876E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.567210E-04 |
| Normal-vs-Stage2 |
6.141500E-02 |
| Normal-vs-Stage3 |
1.55227999999452E-05 |
| Normal-vs-Stage4 |
8.225300E-04 |
| Stage1-vs-Stage2 |
8.169600E-01 |
| Stage1-vs-Stage3 |
1.538580E-01 |
| Stage1-vs-Stage4 |
6.354000E-01 |
| Stage2-vs-Stage3 |
3.068000E-01 |
| Stage2-vs-Stage4 |
6.153800E-01 |
| Stage3-vs-Stage4 |
4.903200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66782999999615E-05 |
| Normal-vs-AfricanAmerican |
5.777500E-04 |
| Normal-vs-Asian |
8.562000E-03 |
| Caucasian-vs-AfricanAmerican |
5.160600E-01 |
| Caucasian-vs-Asian |
4.653000E-01 |
| AfricanAmerican-vs-Asian |
6.103000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38909999952897E-07 |
| Normal-vs-Female |
6.323900E-03 |
| Male-vs-Female |
2.872000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62596999999653E-05 |
| Normal-vs-Age(41-60Yrs) |
1.373000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.84300000000337E-05 |
| Normal-vs-Age(81-100Yrs) |
1.877820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.425700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.087250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.302100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.772200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.156200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.309600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.891800E-01 |
| Normal-vs-Grade 2 |
2.078700E-03 |
| Normal-vs-Grade 3 |
4.07940000002327E-06 |
| Normal-vs-Grade 4 |
3.19130000003831E-06 |
| Grade 1-vs-Grade 2 |
8.068800E-01 |
| Grade 1-vs-Grade 3 |
4.098400E-01 |
| Grade 1-vs-Grade 4 |
1.910840E-01 |
| Grade 2-vs-Grade 3 |
1.234240E-01 |
| Grade 2-vs-Grade 4 |
3.348000E-02 |
| Grade 3-vs-Grade 4 |
2.771600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.372200E-01 |
| Normal-vs-ccB subtype |
2.11280004602798E-09 |
| ccA subtype-vs-ccB subtype |
1.09439999995686E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.791380E-04 |
| Normal-vs-N1 |
5.965900E-02 |
| N0-vs-N1 |
6.131600E-01 |
|
|
